¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : ºÐ¼® À¯Çüº°, ¿ëµµº°, Àü°³ Çüź°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2026-2032³â)
Big Data Analytics In Healthcare Market By Analytics Type, By Application, By Deployment, By End-Users, Region For 2026-2032
»óǰÄÚµå : 1733185
¸®¼­Ä¡»ç : Verified Market Research
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 202 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,403,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. º¸°í¼­ÀÇ ´Ù¿î·Îµå¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 4,850 £Ü 6,635,000
PDF & Excel (5 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. º¸°í¼­ÀÇ ´Ù¿î·Îµå¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 7,550 £Ü 10,329,000
PDF & Excel (Enterprise User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿Àϱâ¾÷³» ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. º¸°í¼­ÀÇ ´Ù¿î·Îµå¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå Æò°¡, 2026-2032³â

Áý´Ü °Ç°­ °ü¸®¸¦ À§ÇÑ ºÐ¼® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °Ç°­ °ü¸® ¹× Àü·« ÃÖÀûÈ­¸¦ À§ÇÑ ºñÁî´Ï½º ÀÎÅÚ¸®Àü½º¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, ÇコÄÉ¾î »ê¾÷¿¡¼­ ºòµ¥ÀÌÅÍ µµÀÔ ±ÞÁõÀ¸·Î ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ Verified Market ResearchÀÇ ¾Ö³Î¸®½ºÆ®¿¡ µû¸£¸é, ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå ±Ô¸ð´Â 2024³â 372¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 748¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼ö·® ±âÁØ¿¡¼­ ±Ý¾× ±âÁØ Áø·á ¸ðµ¨·Î ÀüȯÇÔ¿¡ µû¶ó ȯÀÚ °á°ú¸¦ Æò°¡Çϰí ÀÇ·á ¼­ºñ½º Á¦°øÀ» ÃÖÀûÈ­Çϱâ À§ÇØ °­·ÂÇÑ µ¥ÀÌÅÍ ºÐ¼®ÀÌ ÇÊ¿äÇØÁü¿¡ µû¶ó ºòµ¥ÀÌÅÍ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀº 2026-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 9.12%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå Á¤ÀÇ ¹× °³¿ä

ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼®Àº Á¾Á¾ °Ç°­ ºÐ¼®À̶ó°íµµ ºÒ¸®´Âµ¥, ´ë·®ÀÇ º¹ÀâÇÑ ÀÇ·á °ü·Ã µ¥ÀÌÅ͸¦ ¼öÁý, ºÐ¼®, ÇØ¼®ÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°ø ¹× ÀÇ»ç°áÁ¤À» °­È­ÇÒ ¼ö ÀÖ´Â ÀÇ¹Ì ÀÖ´Â ÀλçÀÌÆ®¸¦ µµÃâÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. ÀÌ ºÎ¹®¿¡´Â ÀüÀÚ ÀÇ·á ±â·Ï(EHR), À¯Àüü µ¥ÀÌÅÍ, ½Ç½Ã°£ ȯÀÚ Á¤º¸ µî ´Ù¾çÇÑ À¯ÇüÀÇ µ¥ÀÌÅͰ¡ Æ÷ÇԵǸç, À̸¦ ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ÆÐÅÏÀ» ÆÄ¾ÇÇÏ°í °á°ú¸¦ ¿¹ÃøÇϸç ȯÀÚ Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºòµ¥ÀÌÅÍ ºÐ¼®Àº ¿¹Ãø ¸ðµ¨¸µ ¹× ¸Ó½Å·¯´×°ú °°Àº °í±Þ ºÐ¼® ±â¼úÀ» Ȱ¿ëÇÏ¿© ÀÇ·á Àü¹®°¡µéÀÌ È¯ÀÚ °á°ú °³¼±, ºñ¿ë Àý°¨, ÀÚ¿ø ¹èºÐ ÃÖÀûÈ­¸¦ À§ÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ´Ù¾çÇÑ µ¥ÀÌÅÍ ¼Ò½ºÀÇ ÅëÇÕÀº ȯÀÚ °³°³ÀÎÀÇ ´ÏÁ ´õ ±íÀÌ ÀÌÇØÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, Áý´Ü ÀüüÀÇ Ãß¼¼¿Í À§Çè ¿äÀÎÀ» ÆÄ¾ÇÇÏ¿© º¸´Ù ±¤¹üÀ§ÇÑ °øÁߺ¸°Ç ÀÌ´Ï¼ÅÆ¼ºê¸¦ Áö¿øÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀüÀÚÀǹ«±â·Ï(EHR) µµÀÔ È®´ë´Â ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ¼ö¿ä¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

ÀüÀڰǰ­±â·Ï(EHR)ÀÇ º¸±Þ È®´ë´Â ÇコÄÉ¾î ºÐ¾ßÀÇ ºòµ¥ÀÌÅÍ ºÐ¼® ¼ö¿ä¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, EHRÀº Á¾ÇÕÀûÀÌ°í ½±°Ô Á¢±ÙÇÒ ¼ö Àִ ȯÀÚ µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á ÇコÄɾî Àü¹®°¡µéÀÌ °í±Þ ºÐ¼® ±â¼úÀ» Ȱ¿ëÇÏ¿© ȯÀÚ Ä¡·á¿Í ¾÷¹« È¿À²¼ºÀ» °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¹Ì±¹ º¸°Çº¹ÁöºÎ(Department of Health and Human Services)¿¡ µû¸£¸é, 85% ÀÌ»óÀÇ º´¿ø ÀÇ»çµéÀÌ EHR ½Ã½ºÅÛÀ» µµÀÔÇÏ¿© ÀÇ·áÁø °£ÀÇ ¿øÈ°ÇÑ È¯ÀÚ Á¤º¸ ±³È¯À» ÃËÁøÇϰí, Áø·áÀÇ Çù·Â°ú ÁúÀ» Çâ»ó½Ã۰í ÀÖÀ¸¸ç, EHRÀº ¹æ´ëÇÑ ¾çÀÇ ÀÓ»ó µ¥ÀÌÅ͸¦ ÅëÇÕÇÏ¿© °Ç°­ °á°ú¸¦ ¿¹ÃøÇϰí, °íÀ§Ç豺À» ½Äº°ÇÒ ¼ö ÀÖ´Â ¿¹Ãø ºÐ¼® ¸ðµ¨À» °³¹ßÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ºÐ¼® ¸ðµ¨ °³¹ßÀ» Áö¿øÇÏ¿© ±Ã±ØÀûÀ¸·Î ´õ ³ªÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» ÃËÁøÇÕ´Ï´Ù.

¶ÇÇÑ, EHR µµÀÔÀÌ Åõ¾à ¿À·ù¸¦ ÁÙÀ̰í ÀÓ»ó Áöħ ÁؼöÀ²À» ³ôÀδٴ ¿¬±¸ °á°úµµ ÀÖ¾î, ÀÇ·á ¼­ºñ½º Á¦°ø °­È­¿¡ ÀÖ¾î µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¿ªÇÒÀÌ ´õ¿í °­Á¶µÇ°í ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î EHR°ú ºòµ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕÀº °³ÀÎ ¸ÂÃãÇü ÀǷḦ ÃËÁøÇϰí Àü¹ÝÀûÀÎ °Ç°­ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÀÖ¾î Áß¿äÇÑ ¿ä¼Ò·Î ¿©°ÜÁö°í ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ±¸Çö°ú °ü·ÃµÈ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾ÈÀÇ ÁÖ¿ä °ü½É»ç´Â ¹«¾ùÀΰ¡?

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ºòµ¥ÀÌÅÍ ºÐ¼® ±¸ÇöÀº ¸î °¡Áö ½É°¢ÇÑ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È ¹®Á¦¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ÀÇ·á µ¥ÀÌÅÍ´Â ±â¹Ð¼ºÀÌ ³ô±â ¶§¹®¿¡ ¹«´Ü Á¢±Ù ¹× Ä§ÇØÀÇ À§ÇèÀÌ ³ôÀ¸¸ç, ÀÇ·á±â°üÀÇ ¾à 93%°¡ µ¥ÀÌÅÍ Ä§ÇØ¸¦ °æÇèÇÑ °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ³î¶ó¿î Åë°è´Â µðÁöÅÐÈ­°¡ ÁøÇàµÇ´Â »óȲ¿¡¼­ ȯÀÚ Á¤º¸°¡ ¾ó¸¶³ª Ãë¾àÇÑÁö Àß º¸¿©ÁÝ´Ï´Ù.

ÇÁ¶óÀ̹ö½Ã Ä§ÇØ´Â ¹æ´ëÇÑ ¾çÀÇ °³ÀÎ °Ç°­ Á¤º¸ÀÇ ¼öÁý°ú °øÀ¯¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â ÀüÀÚ ÀÇ·á ±â·Ï(EHR)ÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ¸·Î ÀÎÇØ Á¾Á¾ ¾ÇÈ­µË´Ï´Ù.

¹Ì±¹ º¸°Çº¹ÁöºÎ¿¡ µû¸£¸é, HIPAA¿Í °°Àº ±ÔÁ¦´Â ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¸¦ º¸È£Çϵµ·Ï ¼³°èµÇ¾úÁö¸¸, ƯÈ÷ ȯÀÚÀÇ ÃæºÐÇÑ µ¿ÀÇ ¾øÀÌ ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ °øÀ¯ÇÏ´Â °Í¿¡ °üÇØ¼­´Â ¿©ÀüÈ÷ °ÝÂ÷°¡ Á¸ÀçÇÑ´Ù°í ÇÕ´Ï´Ù. ±× °á°ú, µ¥ÀÌÅÍ ³ëÃâ·Î ÀÎÇÑ ÀáÀçÀû Â÷º°, °³ÀÎÁ¤º¸ µµ¿ë, Á¤½ÅÀû °íÅë¿¡ ´ëÇÑ ¿ì·Á°¡ ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü »çÀÌ¿¡¼­ È®»êµÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¸¦ ÁؼöÇϸ鼭 ÀÌ·¯ÇÑ À§ÇèÀ» ¿ÏÈ­Çϱâ À§ÇØ °í±Þ ¾Ïȣȭ ±â¼ú°ú °­·ÂÇÑ °Å¹ö³Í½º °üÇàÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå VERIFIED MARKET RESEARCHÀÇ Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå Àü¸Á

Á¦5Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : ºÐ¼® À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : Àü°³ Çüź°

Á¦9Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : Áö¿ªº°

Á¦10Àå ¼¼°èÀÇ ÇコÄÉ¾î ºòµ¥ÀÌÅÍ ºÐ¼® ½ÃÀå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Big Data Analytics In Healthcare Market Valuation - 2026-2032

The increase in demand for analytics solutions for population health management, the rise in the need for business intelligence to optimize health administration and strategy, and the surge in the adoption of big data in the healthcare industry are the factors that drive the growth of the market. According to the analyst from Verified Market Research, the big data analytics in healthcare market size is estimated at USD 37.22 Billion in 2024, and is expected to reach USD 74.82 Billion by 2032.

The transition from volume-based to value-based care models necessitates robust data analytics to assess patient outcomes and optimize healthcare delivery, driving demand for big data solutions. The big data analytics in healthcare market is projected to grow at a CAGR of 9.12% during the forecast period 2026-2032.

Big Data Analytics In Healthcare Market: Definition/ Overview

Big Data Analytics in Healthcare, often referred to as health analytics, is the process of collecting, analyzing, and interpreting large volumes of complex health-related data to derive meaningful insights that can enhance healthcare delivery and decision-making. This field encompasses various data types, including electronic health records (EHRs), genomic data, and real-time patient information, allowing healthcare providers to identify patterns, predict outcomes, and improve patient care.

By leveraging advanced analytical techniques, such as predictive modeling and machine learning, Big Data Analytics enables healthcare professionals to make informed decisions that can lead to better patient outcomes, reduced costs, and optimized resource allocation. The integration of diverse data sources not only facilitates a deeper understanding of individual patient needs but also supports broader public health initiatives by identifying trends and risk factors across populations.

How is the Growing Adoption of Electronic Health Records (EHRs) Influencing the Demand for Big Data Analytics in Healthcare?

The growing adoption of Electronic Health Records (EHRs) is significantly influencing the demand for Big Data Analytics in healthcare. EHRs, by providing comprehensive and accessible patient data, are enabling healthcare professionals to leverage advanced analytical techniques to improve patient care and operational efficiency. According to the U.S. Department of Health and Human Services, over 85% of office-based physicians have adopted EHR systems, which has facilitated the seamless exchange of patient information among providers, thereby enhancing care coordination and quality. As EHRs aggregate vast amounts of clinical data, they support the development of predictive analytics models that can forecast health outcomes and identify at-risk populations, ultimately driving better clinical decision-making.

Moreover, studies have shown that EHR implementation is associated with reduced medication errors and improved adherence to clinical guidelines, further underscoring the role of data analytics in enhancing healthcare delivery. Consequently, the integration of EHRs with Big Data Analytics is seen as a critical factor in advancing personalized medicine and improving overall health outcomes.

What are the Primary Data Privacy and Security Concerns Associated With the Implementation of Big Data Analytics in Healthcare?

The implementation of Big Data Analytics in healthcare is associated with several significant data privacy and security concerns. The sensitive nature of medical data raises the risk of unauthorized access and breaches, with reports indicating that approximately 93% of healthcare organizations have experienced a data breach at some point. This alarming statistic highlights the vulnerability of patient information in an increasingly digital landscape.

Privacy violations are often exacerbated by the extensive use of electronic health records (EHRs), which facilitate the collection and sharing of vast amounts of personal health information.

According to the U.S. Department of Health and Human Services, regulations such as HIPAA are designed to protect patient privacy; however, gaps still exist, particularly concerning the sharing of large datasets without adequate patient consent. As a result, concerns about potential discrimination, identity theft, and emotional distress due to data exposure are prevalent among patients and healthcare providers alike. Consequently, the need for advanced encryption methods and robust governance practices is emphasized to mitigate these risks while ensuring compliance with regulatory frameworks.

Category-Wise Acumens

How is Predictive Analytics Being Utilized to Anticipate Patient Outcomes and Improve Clinical Decision-Making in Healthcare?

Predictive analytics is being utilized in healthcare to anticipate patient outcomes and enhance clinical decision-making through the analysis of historical and real-time data. By employing advanced algorithms and machine learning techniques, healthcare providers are able to identify patterns and correlations within vast datasets, which allows for the forecasting of potential health events. According to the Centers for Disease Control and Prevention, over 60% of healthcare organizations are currently using predictive analytics to improve patient health outcomes and operational efficiency. For instance, predictive models can assess a patient's risk of developing chronic diseases, enabling early interventions that can significantly improve recovery rates.

Additionally, these analytics facilitate personalized treatment plans tailored to individual patient profiles, which enhances the effectiveness of care. As a result, clinicians are empowered with actionable insights that support informed decision-making, ultimately leading to better patient outcomes and reduced readmission rates.

How is Clinical Analytics Improving Patient Care Through Real-Time Monitoring and Personalized Treatment Plans?

Clinical analytics is being leveraged to improve patient care through real-time monitoring and the development of personalized treatment plans. By utilizing advanced data analytics, healthcare providers are able to continuously track patient health metrics, which facilitates timely interventions when changes in a patient's condition are detected. According to the U.S. Department of Health and Human Services, approximately 70% of healthcare organizations have implemented real-time analytics systems to enhance patient monitoring capabilities.

This technology allows for immediate alerts regarding critical changes in vital signs, enabling clinicians to respond swiftly and effectively.

Additionally, personalized treatment plans are being informed by comprehensive patient data, which includes historical health records and real-time health metrics. This integration of data supports tailored interventions that align with individual patient needs, ultimately leading to improved health outcomes. As a result, the quality of care is enhanced, and unnecessary hospitalizations can be reduced, demonstrating the significant impact of clinical analytics on modern healthcare practices.

Country/Region-wise Acumens

How does the Presence of Major Healthcare Analytics Companies and Technology Providers in North America Influence the Region's Leadership in the Market?

The presence of major healthcare analytics companies and technology providers in North America significantly influences the region's leadership in the market by fostering innovation, enhancing competition, and driving widespread adoption of advanced analytics solutions.

With key players such as McKesson Corporation, IBM, and Optum leading the charge, substantial investments are being made in research and development, which accelerates the creation of cutting-edge technologies tailored to healthcare needs. According to the U.S. Department of Health and Human Services, approximately 83% of the North American healthcare analytics market is attributed to U.S. companies, underscoring the dominance of this region. The collaboration between these companies and healthcare institutions facilitates the integration of analytics into clinical workflows, improving patient outcomes through data- driven decision-making.

Furthermore, government initiatives, such as the National Health Information Technology (HIT) initiative, promote interoperability and data sharing, which are essential for maximizing the benefits of analytics in healthcare. As a result, North America is positioned as a leader in healthcare analytics, characterized by a robust ecosystem that supports continuous improvement in patient care and operational efficiency.

What Role do European Healthcare Regulations, Such as GDPR, Play in Shaping the Adoption and Growth of Big Data Analytics in the Region?

European healthcare regulations, particularly the General Data Protection Regulation (GDPR), play a crucial role in shaping the adoption and growth of Big Data Analytics in the region. By establishing stringent standards for data protection and privacy, GDPR mandates that healthcare organizations implement robust security measures and obtain explicit consent from patients before processing their personal health information. According to the European Commission, approximately 75% of EU citizens express concerns about how their personal data is used, highlighting the importance of trust in healthcare analytics.

The regulation also emphasizes transparency, requiring organizations to inform patients about how their data will be utilized, thus fostering a patient-centered approach to data management. Furthermore, GDPR grants patients significant rights over their data, such as the right to access and the right to be forgotten, which necessitates healthcare providers to develop systems that comply with these requirements. As a result, while GDPR may initially pose challenges for data sharing and analytics, it ultimately encourages the development of secure and ethical data practices that can enhance patient care and drive innovation in healthcare analytics across Europe.

Competitive Landscape

The competitive landscape of the Big Data Analytics market is characterized by intense rivalry among established giants and emerging players, each vying for market share through innovation and strategic partnerships.

Big Data Analytics In Healthcare Market, By Category

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

4 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET OUTLOOK

5 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET, BY ANALYTICS TYPE

6 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET, BY APPLICATION

7 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET, BY END-USERS

8 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET, BY DEPLOYMENT

9 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET, BY GEOGRAPHY

10 GLOBAL BIG DATA ANALYTICS IN HEALTHCARE MARKET COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â